Pramod Gupta's most recent trade in Unicycive Therapeutics Inc was a trade of 81,750 Stock Options done . Disclosure was reported to the exchange on Aug. 12, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Unicycive Therapeutics Inc | Pramod Gupta | EVP, Pharmaceuticals and BD | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Aug 2024 | 81,750 | 2,119,862 | - | - | Stock Options | |
| Unicycive Therapeutics Inc | Pramod Gupta | EVP, Pharmaceuticals and BD | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Apr 2024 | 463,250 | 2,038,112 | - | - | Stock Options | |
| Unicycive Therapeutics Inc | Pramod Gupta | EVP, Pharmaceuticals and BD | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Aug 2023 | 1,355,000 | 1,574,862 | - | - | Stock Options | |
| Unicycive Therapeutics Inc | Pramod Gupta | EVP, Pharmaceuticals and BD | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Jul 2023 | 46,110 | 46,110 | - | - | Warrant (right to buy) | |
| Unicycive Therapeutics Inc | Pramod Gupta | EVP, Pharmaceuticals and BD | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Jul 2023 | 41,845 | 41,845 | - | - | Common Stock | |
| Unicycive Therapeutics Inc | Pramod Gupta | EVP, Pharmaceuticals and BD | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Jul 2023 | 31,700 | 31,700 | - | - | Warrant (right to buy | |
| Unicycive Therapeutics Inc | Pramod Gupta | EVP, Pharmaceuticals and BD | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Jul 2023 | 28,818 | 28,818 | - | - | Warrant (right to buy) | |
| Unicycive Therapeutics Inc | Pramod Gupta | EVP, Pharmaceuticals and BD | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Jul 2023 | 20 | 0 | - | - | Series A-1 Convertible Preferred Stock | |
| Unicycive Therapeutics Inc | Pramod Gupta | EVP, Pharmaceuticals and BD | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2023 | 20 | 20 | - | - | Series A Convertible Preferred Stock | |
| Unicycive Therapeutics Inc | Pramod Gupta | EVP, Pharmaceuticals and BD | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Nov 2022 | 28,000 | 219,862 | - | - | Stock Options | |
| Unicycive Therapeutics Inc | Pramod Gupta | EVP, Pharmaceuticals and BD | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jul 2021 | 34,884 | 191,862 | - | - | Stock Options |